ORBIMED ADVISORS LLC – OncoCyte Corporation Transaction History
ORBIMED ADVISORS LLC portfolio value:
$1.37M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
-18.86%
quarter
OncoCyte Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -33.65% | -955.03K shares | -1.17M | $0.73 | 1.88M |
| Q2 2022 | share | Decrease | -18.78% | -656K shares | -2.65M | $0.9 | 2.83M |
| Q1 2022 | share | 0.00% | 0 shares | -2.37M | $1.49 | 3.49M | |
| Q4 2021 | share | Increase | +22.33% | 637.8K shares | -2.58M | $2.04 | 3.49M |
| Q3 2021 | share | Increase | +36.00% | 756K shares | -1.88M | $3.56 | 2.85M |
| Q2 2021 | share | 0.00% | 0 shares | 1.15M | $5.74 | 2.1M | |
| Q1 2021 | share | Increase | 0.00% | 2.1M shares | 10.89M | $5.19 | 2.1M |